COVID19 vaccination choice among Iraqi students at Al-Zahraa University for women.

F1000Res

Medical and Health Technology College, Al- Zahra University for Women, Karbala, Karbala, Iraq.

Published: August 2022

COVID19 vaccine rejection is a global issue that most developing countries face. A study of COVID-19 vaccine preference among Al-Zahraa University female students will pave the way to resolving the issue of vaccine rejection among students. Vaccine hesitation refers to a delay in accepting or refusing immunization despite the fact that vaccination services are readily available. Students' preferences and refusals of the COVID19 vaccine were evaluated to determine the reasons for their decisions.  This study involved 198 students from Al-Zahraa University for women. An observational cross-sectional study was conducted at Al-Zahraa University in Karbala, Iraq, to find out which Health and Medical Technology students preferred the COVID19 vaccine. Tests based on statistics made use of frequency and rate data.   Most students (95%) were over the age of 19. The COVID-19 vaccine was rejected by 138 people (70.4%).  A total of 43 students (28.5%) believed that the COVID19 vaccine may not be completely safe. 49.3% of students were not aware of the differences between the various types of vaccines.  Pfizer was the most preferred by 64 (34.8%), AstraZeneca by 17 (9.2%), and Chinse-Sinovac by only 11 (6%). 20 students (16.4%) believed that with the vaccine they could return to life as it was before the COVID-19 pandemic. Covid-19 vaccine acceptance among Al-Zahara University students may be low in part because of myths, and partly because of the fear of side-effects associated with the vaccine.    Information about COVID-19 vaccines should be transparently communicated to the media by health authorities to help the public make informed decisions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280114PMC
http://dx.doi.org/10.12688/f1000research.55552.2DOI Listing

Publication Analysis

Top Keywords

covid19 vaccine
12
students
8
vaccine
7
covid19
4
covid19 vaccination
4
vaccination choice
4
choice iraqi
4
iraqi students
4
students al-zahraa
4
al-zahraa university
4

Similar Publications

After the global impact of the COVID-19 pandemic, concerns over virus transmission have risen. A state of health emergency was declared in 2022 due to Clade 2 of the monkeypox (MPOX) virus. In August 2024, another emergency was declared by the World Health Organization (WHO) because of the widespread Clade 1b, which caused a more severe and lethal disease.

View Article and Find Full Text PDF

Lipid nanoparticles (LNPs) are the most advanced delivery system currently available for RNA therapeutics. Their development has accelerated since the success of Patisiran, the first siRNA-LNP therapeutic, and the mRNA vaccines that emerged during the COVID-19 pandemic. Designing LNPs with specific targeting, high potency, and minimal side effects is crucial for their successful clinical use.

View Article and Find Full Text PDF

Pathogen sequencing is an important tool for disease surveillance and demonstrated its high value during the COVID-19 pandemic. Viral sequencing during the pandemic allowed us to track disease spread, quickly identify new variants, and guide the development of vaccines. Tiled amplicon sequencing, in which a panel of primers is used for multiplex amplification of fragments across an entire genome, was the cornerstone of SARS-CoV-2 sequencing.

View Article and Find Full Text PDF

Background: In SARS-CoV-2 infection, cytokines and laboratory biomarkers play a key role in disease progression and their long-term levels have been associated with the outcome of long COVID-19.

Objectives: I) study the levels of cytokines, hematological and biochemical biomarkers in the acute and post-acute phases of COVID-19 disease; and II) assess the impact of COVID-19 vaccine doses on fatigue symptoms.

Methods: This study is an exploratory cohort nested within a clinical and laboratory follow-up of surviving participants after pre-vaccine acute COVID-19 infection with severe clinical manifestations.

View Article and Find Full Text PDF

Immunogenicity of the CoronaVac vaccine in children: a real-world study.

Front Immunol

January 2025

Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia.

Background: Despite its proven effectiveness and safety, there are limited real-world data on CoronaVac's immunogenicity in children, especially in lower-income countries, particularly for SARS-CoV-2 variants. We present a real-world study evaluating CoronaVac's immunogenicity in Colombian children stratified by previous exposure to this virus.

Methods: 89 children aged 3-11 years were enrolled (50 Non-Exposed and 39 Exposed).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!